Use of diuretics in hypertensive patients with metabolic disturbances
The multicenter research MERSY (Moxonidine Efficacy on blood pressure Reduction revealed in a metabolic SYndrome population) finished in 2008 was devoted to an assessment of long-term safety and efficiency of agonist I2-imidazolin receptors – moxonidine in patients with arterial hypertension and met...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IP Morozov P.V.
2013-06-01
|
| Series: | Системные гипертензии |
| Subjects: | |
| Online Access: | https://syst-hypertension.ru/2075-082X/article/view/28964 |
| id |
doaj-dcc7f11c40c14242a664eb015d65b891 |
|---|---|
| record_format |
Article |
| spelling |
doaj-dcc7f11c40c14242a664eb015d65b8912020-11-25T03:06:38ZrusIP Morozov P.V.Системные гипертензии2075-082X2542-21892013-06-01102344026065Use of diuretics in hypertensive patients with metabolic disturbancesYuliya Valer'evna ZhernakovaIrina Evgen'evna ChazovaThe multicenter research MERSY (Moxonidine Efficacy on blood pressure Reduction revealed in a metabolic SYndrome population) finished in 2008 was devoted to an assessment of long-term safety and efficiency of agonist I2-imidazolin receptors – moxonidine in patients with arterial hypertension and metabolic syndrome (in the general group and in advance defined subgroup of patients in a postmenopause). In 2013 final international results of the research MERSY which showed high antihypertensive activity of moxonidine, and also its positive influence on metabolic parameters and mass of a body were published.https://syst-hypertension.ru/2075-082X/article/view/28964metabolic syndromearterial hypertensionobesityindapamide retard |
| collection |
DOAJ |
| language |
Russian |
| format |
Article |
| sources |
DOAJ |
| author |
Yuliya Valer'evna Zhernakova Irina Evgen'evna Chazova |
| spellingShingle |
Yuliya Valer'evna Zhernakova Irina Evgen'evna Chazova Use of diuretics in hypertensive patients with metabolic disturbances Системные гипертензии metabolic syndrome arterial hypertension obesity indapamide retard |
| author_facet |
Yuliya Valer'evna Zhernakova Irina Evgen'evna Chazova |
| author_sort |
Yuliya Valer'evna Zhernakova |
| title |
Use of diuretics in hypertensive patients with metabolic disturbances |
| title_short |
Use of diuretics in hypertensive patients with metabolic disturbances |
| title_full |
Use of diuretics in hypertensive patients with metabolic disturbances |
| title_fullStr |
Use of diuretics in hypertensive patients with metabolic disturbances |
| title_full_unstemmed |
Use of diuretics in hypertensive patients with metabolic disturbances |
| title_sort |
use of diuretics in hypertensive patients with metabolic disturbances |
| publisher |
IP Morozov P.V. |
| series |
Системные гипертензии |
| issn |
2075-082X 2542-2189 |
| publishDate |
2013-06-01 |
| description |
The multicenter research MERSY (Moxonidine Efficacy on blood pressure Reduction revealed in a metabolic SYndrome population) finished in 2008 was devoted to an assessment of long-term safety and efficiency of agonist I2-imidazolin receptors – moxonidine in patients with arterial hypertension and metabolic syndrome (in the general group and in advance defined subgroup of patients in a postmenopause). In 2013 final international results of the research MERSY which showed high antihypertensive activity of moxonidine, and also its positive influence on metabolic parameters and mass of a body were published. |
| topic |
metabolic syndrome arterial hypertension obesity indapamide retard |
| url |
https://syst-hypertension.ru/2075-082X/article/view/28964 |
| work_keys_str_mv |
AT yuliyavalerevnazhernakova useofdiureticsinhypertensivepatientswithmetabolicdisturbances AT irinaevgenevnachazova useofdiureticsinhypertensivepatientswithmetabolicdisturbances |
| _version_ |
1724673246458019840 |